{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:51:20Z","timestamp":1789001480636,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"POS SALUTE PROGETTO T3-AN-18 SISAGEN-CARDIO (Sistema Integrato Sanitario per le malattie GEnetiche CARDIOvascolari), .","award":["CUP F83C22001400001"],"award-info":[{"award-number":["CUP F83C22001400001"]}]},{"name":"POS SALUTE PROGETTO T3-AN-18 SISAGEN-CARDIO (Sistema Integrato Sanitario per le malattie GEnetiche CARDIOvascolari), .","award":["CUP F83C22001400001"],"award-info":[{"award-number":["CUP F83C22001400001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-09443-8","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T14:17:42Z","timestamp":1759241862000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Computational repurposing of drugs against dengue virus targeting NS5 and methyltransferase proteins"],"prefix":"10.1038","volume":"15","author":[{"given":"Murthaeti","family":"Yaswanth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Tufail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subrata","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saravanan","family":"Janardhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Maffia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ragusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipin Kumar","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"issue":"1","key":"9443_CR1","first-page":"1","volume":"2","author":"MG Guzman","year":"2016","unstructured":"Guzman, M. G. Dengue infection. Nat. Reviews Disease Primers. 2 (1), 1\u201325 (2016).","journal-title":"Nat. Reviews Disease Primers"},{"issue":"9","key":"9443_CR2","doi-asserted-by":"publisher","first-page":"e0257460","DOI":"10.1371\/journal.pone.0257460","volume":"16","author":"P Nonyong","year":"2021","unstructured":"Nonyong, P. Dengue virus in humans and mosquitoes and their molecular characteristics in Northeastern Thailand 2016\u20132018. PloS One. 16 (9), e0257460 (2021).","journal-title":"PloS One"},{"issue":"26","key":"9443_CR3","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1056\/NEJM197112232852606","volume":"285","author":"N Ehrenkranz","year":"1971","unstructured":"Ehrenkranz, N. et al. Pandemic dengue in Caribbean countries and the Southern united States\u2014past, present and potential problems. N. Engl. J. Med. 285 (26), 1460\u20131469 (1971).","journal-title":"N. Engl. J. Med."},{"key":"9443_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/6803098","volume":"3","author":"N Khetarpal","year":"2016","unstructured":"Khetarpal, N. & Khanna, I. Dengue fever: causes, complications, and vaccine strategies. J. Immunol. Res. 3, 1\u201314 (2016).","journal-title":"J. Immunol. Res."},{"key":"9443_CR5","doi-asserted-by":"publisher","first-page":"e1760","DOI":"10.1371\/journal.pntd.0001760","volume":"8","author":"OJ Brady","year":"2012","unstructured":"Brady, O. J. et al. Refining the global Spatial limits of dengue virus transmission by Evidence-Based consensus. Reithinger R. PLoS Negl. Trop. Dis. 8, e1760 (2012).","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"9443_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.5334\/gh.1254","volume":"18","author":"R Cristodulo","year":"2023","unstructured":"Cristodulo, R. et al. Dengue myocarditis: A case report and major review. Glob Heart. 18 (1), 41. https:\/\/doi.org\/10.5334\/gh.1254 (2023). PMID: 37547170; PMCID: PMC10402786.","journal-title":"Glob Heart"},{"key":"9443_CR7","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.antiviral.2018.12.016","volume":"163","author":"SP Lim","year":"2019","unstructured":"Lim, S. P. Dengue drug discovery: progress, challenges and outlook. Antiviral Res. 163, 156\u2013178 (2019).","journal-title":"Antiviral Res."},{"issue":"4","key":"9443_CR8","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1128\/CMR.3.4.376","volume":"3","author":"EA Henchal","year":"1990","unstructured":"Henchal, E. A. & Putnak, J. R. The dengue viruses. Clin. Microbiol. Rev. 3 (4), 376\u2013396 (1990).","journal-title":"Clin. Microbiol. Rev."},{"key":"9443_CR9","doi-asserted-by":"publisher","unstructured":"Richard, J. K. et al. Structure of Dengue Virus; Implications for Flavivirus Organization, Maturation, and Fusion. Cell. 108 (5), 717\u2013725. https:\/\/doi.org\/10.1016\/S0092-8674(02)00660-8 (2022)","DOI":"10.1016\/S0092-8674(02)00660-8"},{"issue":"3","key":"9443_CR10","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jmb.2009.07.035","volume":"392","author":"MN Melo","year":"2009","unstructured":"Melo, M. N. Interaction of the dengue virus fusion peptide with membranes assessed by NMR: the essential role of the envelope protein Trp101 for membrane fusion. J. Mol. Biol. 392 (3), 736\u2013746 (2009).","journal-title":"J. Mol. Biol."},{"key":"9443_CR11","doi-asserted-by":"crossref","unstructured":"Chatel-Chaix, L. et al. Dengue virus perturbs mitochondrial Morpho dynamics to dampen innate immune responses. Cell Host Microbe. 20 (3), 342\u2013356 (2016).","DOI":"10.1016\/j.chom.2016.07.008"},{"key":"9443_CR12","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.virol.2013.08.006","volume":"446","author":"L Yu","year":"2013","unstructured":"Yu, L., Takeda, K. & Markoff, L. Protein-protein interactions among West nile non-structural proteins and transmembrane complex formation in mammalian cells. Virology 446, 365\u2013377 (2013).","journal-title":"Virology"},{"key":"9443_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/v9040091","volume":"9","author":"A El Sahili","year":"2017","unstructured":"El Sahili, A. & Lescar, J. Dengue virus Non-Structural protein 5. Viruses 9, 91 (2017).","journal-title":"Viruses"},{"key":"9443_CR14","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.antiviral.2015.03.014","volume":"118","author":"D Luo","year":"2015","unstructured":"Luo, D., Vasudevan, S. G. & Lescar, J. The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development. Antiviral Res. 118, 148\u2013158 (2015).","journal-title":"Antiviral Res."},{"issue":"5","key":"9443_CR15","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1128\/AAC.01148-08","volume":"53","author":"QY Wang","year":"2009","unstructured":"Wang, Q. Y. A small-molecule dengue virus entry inhibitor. Antimicrob. Agents Chemother. 53 (5), 1823\u20131831 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9443_CR16","first-page":"137","volume":"320","author":"KKS Ng","year":"2008","unstructured":"Ng, K. K. S., Arnold, J. J. & Cameron, C. E. Structure-Function relationships among RNA-Dependent RNA polymerases. Curr. Top. Microbiol. Immunol. 320, 137\u2013156 (2008).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"9443_CR17","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1039\/b514294f","volume":"25","author":"MS Butler","year":"2008","unstructured":"Butler, M. S. Natural products to drugs: natural product-derived compounds in clinical trials. Nat. Prod. Rep. 25, 475\u2013516 (2008).","journal-title":"Nat. Prod. Rep."},{"issue":"62","key":"9443_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.21660\/2019.62.4650","volume":"17","author":"AH Natalia","year":"2019","unstructured":"Natalia, A. H., Alkaff, A. H., Saragih, M., Istiqomah, I. N. & Tambunan, U. S. F. Fragment based drug design to inhibit DNA methyltransferase 1 (DNMT1) for breast cancer therapy. Int. J. GEOMATE. 17 (62), 35\u201340 (2019).","journal-title":"Int. J. GEOMATE"},{"key":"9443_CR19","doi-asserted-by":"crossref","unstructured":"Putra, H. H., Saragih, M. & Yulianti; Tambunan, U. S. F. Identification of Natural Product Compounds as NS5 RDRP Inhibitor for Dengue Virus Serotype 1\u20134 through In Silico Analysis; AIP Conf. Proc. 2237, 020030-1-020030-6. (2020).","DOI":"10.1063\/5.0005236"},{"issue":"8","key":"9443_CR20","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1093\/jac\/dks147","volume":"67","author":"E Mastrangelo","year":"2012","unstructured":"Mastrangelo, E. et al. Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug. J. Antimicrob. Chemother. 67 (8), 1884\u20131894 (2012).","journal-title":"J. Antimicrob. Chemother."},{"key":"9443_CR21","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.antiviral.2015.03.010","volume":"118","author":"JJ Hann Chu","year":"2015","unstructured":"Hann Chu, J. J. et al. B.; antiviral activities of 15 dengue NS2B-NS3 protease inhibitors using a human cell-based viral quantification assay. Antiviral Res. 118, 68\u201374 (2015).","journal-title":"Antiviral Res."},{"key":"9443_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.4172\/1948-5964.1000173","volume":"10","author":"E Bosseboeuf","year":"2018","unstructured":"Bosseboeuf, E. et al. Azithromycin inhibits the replication of Zika virus. J. Antivirals Antiretrovirals. 10, 6\u201311 (2018).","journal-title":"J. Antivirals Antiretrovirals"},{"key":"9443_CR23","first-page":"89","volume-title":"Flavivirus Encephalitis","author":"A Baier","year":"2011","unstructured":"Baier, A. Flaviviral infections and potential targets for antiviral therapy. In Flavivirus Encephalitis 1st edn (eds Ruzek, D. & InTech) 89\u2013104 (Rijeka, 2011).","edition":"1"},{"key":"9443_CR24","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41429-020-0336-z","volume":"73","author":"F Heidary","year":"2020","unstructured":"Heidary, F. & Gharebaghi, R. Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen. J. Antibiot. 73, 593\u2013602. https:\/\/doi.org\/10.1038\/s41429-020-0336-z (2020).","journal-title":"J. Antibiot."},{"issue":"16","key":"9443_CR25","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris, G. M. et al. AutoDock4 and AutoDockTools4: automated Docking with selective receptor flexibility. J. Comput. Chem. 30 (16), 2785\u20132279 (2009).","journal-title":"J. Comput. Chem."},{"key":"9443_CR26","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s10930-020-09953-6","volume":"40","author":"V Dalal","year":"2021","unstructured":"Dalal, V. et al. Structure-Based identification of potential drugs against FmtA of Staphylococcus aureus: virtual screening, molecular dynamics, MM-GBSA, and QM\/MM. Protein. J. 40, 148\u2013165 (2021).","journal-title":"Protein. J."},{"key":"9443_CR27","doi-asserted-by":"publisher","first-page":"e202403269","DOI":"10.1002\/slct.202403269","volume":"10","author":"S Verma","year":"2025","unstructured":"Verma, S., Dubey, A., Singh, R., Tayade, R. & Mishra, V. K. In-Silico screening, molecular dynamics, and DFT analysis of ZINC and chembl library compounds for SARS-CoV-2 main protease Inhibition. ChemistrySelect 10, e202403269 (2025).","journal-title":"ChemistrySelect"},{"issue":"9","key":"9443_CR28","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A. & Case, D. A. Development and testing of general amber force field. J. Comput. Chem. 25 (9), 1157\u20131174 (2004).","journal-title":"J. Comput. Chem."},{"issue":"7","key":"9443_CR29","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1021\/ct400341p","volume":"9","author":"DR Roe","year":"2013","unstructured":"Roe, D. R., Cheatham, T. E. III & PTRAJ Software for processing and analysis of molecular dynamics trajectory data. J. Chem. Theory Comput. 9 (7), 3084\u20133095 (2013).","journal-title":"J. Chem. Theory Comput."},{"issue":"1","key":"9443_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey, W., Dalke, A. & Schulten, K. Visual molecular dynamics. J. Mol. Graph. 14 (1), 33\u201338 (1996).","journal-title":"J. Mol. Graph."},{"key":"9443_CR31","unstructured":"The PyMOL Molecular. Graphics System, Version 1.2r3pre, Schr\u00f6dinger, LLC (2010)."},{"issue":"50","key":"9443_CR32","doi-asserted-by":"publisher","first-page":"10605","DOI":"10.1021\/acs.jpcb.9b07917","volume":"123","author":"VK Mishra","year":"2019","unstructured":"Mishra, V. K. & Mishra, S. Origin of Regio- and stereospecific catalysis by 8-Lipoxygenase. J. Phys. Chem. B. 123 (50), 10605\u201310621 (2019).","journal-title":"J. Phys. Chem. B"},{"issue":"28","key":"9443_CR33","doi-asserted-by":"publisher","first-page":"16013","DOI":"10.1039\/D0CP02351E","volume":"22","author":"VK Mishra","year":"2020","unstructured":"Mishra, V. K. & Mishra, S. Flipped regiospecificity in L434F mutant of 8-lipoxygenase. Phys. Chem. Chem. Phys. 22 (28), 16013\u201316022 (2020).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"9443_CR34","doi-asserted-by":"publisher","first-page":"0006","DOI":"10.1016\/j.bbrc.2023.149377","volume":"693","author":"R Singh","year":"2024","unstructured":"Singh, R., Mishra, V. K. & Das, A. K. Crystal structure of a thiolase from archaeal Pyrococcus furiosus and its in Silico functional annotation. Biochem. Biophys. Res. Commun. 693, 0006\u2013291X (2024).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"9443_CR35","first-page":"767","volume":"96","author":"D Dutta","year":"2019","unstructured":"Dutta, D., Mishra, V. K. & Mishra, S. QM\/MM-MD simulation of the catalytic hydrolysis of L-captopril by microbial enzyme DapE. J. Indian Chem. Soc. 96 (7), 767\u2013774 (2019).","journal-title":"J. Indian Chem. Soc."},{"issue":"5","key":"9443_CR36","first-page":"1234","volume":"42","author":"L Qin","year":"2021","unstructured":"Qin, L., Zhang, X. & Wang, J. Dynamic residue-residue correlations in protein-ligand interactions: insights from molecular dynamics simulations. J. Comput. Chem. 42 (5), 1234\u20131242 (2021).","journal-title":"J. Comput. Chem."},{"issue":"2","key":"9443_CR37","first-page":"56","volume":"91","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y., Zhou, Z. & Huang, J. Investigating protein flexibility and ligand binding through dynamic cross-correlation analysis. Proteins Struct. Funct. Bioinform. 91 (2), 56\u201367 (2023).","journal-title":"Proteins Struct. Funct. Bioinform."},{"issue":"15","key":"9443_CR38","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1080\/08927022.2024.2399150","volume":"50","author":"SC Ja\u2019afaru","year":"2024","unstructured":"Ja\u2019afaru, S. C. et al. Computational modeling and molecular dynamics studies of Methyl sulfonyl acetate derivatives as potent SmTGR inhibitors: insights into binding interactions. Mol. Simul. 50 (15), 1274\u20131291 (2024).","journal-title":"Mol. Simul."},{"key":"9443_CR39","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s40203-024-00281-6","volume":"12","author":"SC Ja\u2019afaru","year":"2024","unstructured":"Ja\u2019afaru, S. C. et al. Virtual screening and molecular dynamics studies of novel small molecules targeting Schistosomamansoni DHODH: identification of potential inhibitors. Silico Pharmacol. 12, 113 (2024).","journal-title":"Silico Pharmacol."},{"issue":"7","key":"9443_CR40","first-page":"1199","volume":"47","author":"M Lin","year":"2020","unstructured":"Lin, M., Tang, H. & Chen, R. Mechanistic insights into allosteric modulation of protein targets using MD-based cross-correlation matrices. Mol. Biol. Rep. 47 (7), 1199\u20131210 (2020).","journal-title":"Mol. Biol. Rep."},{"issue":"8","key":"9443_CR41","first-page":"1247","volume":"27","author":"P Karthik","year":"2022","unstructured":"Karthik, P., Das, S. & Sharma, V. Exploring protein dynamics for drug discovery using DCCM and machine learning. Drug Discovery Today. 27 (8), 1247\u20131257 (2022).","journal-title":"Drug Discovery Today"},{"key":"9443_CR42","first-page":"12345","volume":"8","author":"X Liu","year":"2021","unstructured":"Liu, X., Li, H. & Yang, W. Residue-specific correlation analysis in MD simulations: implications for inhibitor design. Front. Mol. Biosci. 8, 12345 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"9443_CR43","first-page":"105873","volume":"108","author":"G Chen","year":"2023","unstructured":"Chen, G., Xu, Z. & Wang, Q. Advancing computational drug discovery through dynamic motion analysis of proteins. Comput. Biol. Chem. 108, 105873 (2023).","journal-title":"Comput. Biol. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09443-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09443-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09443-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T02:09:41Z","timestamp":1759630181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09443-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9443"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-09443-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"14 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"33906"}}